Grant Skrepnek to Risk Assessment
This is a "connection" page, showing publications Grant Skrepnek has written about Risk Assessment.
Connection Strength
0.116
-
An economic and outcomes assessment of first-line monotherapy in the treatment of community-acquired pneumonia within managed care. Curr Med Res Opin. 2005 Feb; 21(2):261-70.
Score: 0.051
-
Optimal Medical Therapy Prescribing Patterns and Disparities Identified in Patients with Acute Coronary Syndromes at an Academic Medical Center in an Area with High Coronary Heart Disease-Related Mortality. Am J Cardiovasc Drugs. 2019 Apr; 19(2):185-193.
Score: 0.034
-
Oncologist preferences for health states associated with the treatment of advanced ovarian cancer. Appl Health Econ Health Policy. 2010; 8(4):217-23.
Score: 0.018
-
Persistence, adherence, and risk of discontinuation associated with commonly prescribed antihypertensive drug monotherapies. J Am Board Fam Med. 2007 Jan-Feb; 20(1):72-80.
Score: 0.014